Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: HAE

Haemonetics Corporation

Healthcare | Medical - Instruments & Supplies

No licensed closing price on file for HAE. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$2.07

Haemonetics Corporation (NYSE: HAE) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 02:39 UTC.

What Haemonetics Corporation does

Haemonetics is a global medical technology company that develops equipment and software for collecting and processing blood plasma and blood components. The company operates through three segments: Plasma, which provides automated collection systems and donor management software for pharmaceutical plasma collection; Blood Center, which supplies collection and processing devices for blood banks; and Hospital, which includes vascular closure, sensor-guided technologies, and blood management products used in surgical settings.

Summarized from Haemonetics Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$2.07
Return on equity12.22%
Debt/equity1.42

Revenue, margins & earnings

FY2022 Net income: $43MFY2022 Taxes & interest: $37MFY2022 Operating expenses: $425MFY2022 Cost of revenue: $488M$993MFY2022FY2023 Net income: $115MFY2023 Taxes & interest: $41MFY2023 Operating expenses: $459MFY2023 Cost of revenue: $554M$1.17BFY2023FY2024 Net income: $118MFY2024 Taxes & interest: $47MFY2024 Operating expenses: $527MFY2024 Cost of revenue: $618M$1.31BFY2024FY2025 Net income: $168MFY2025 Taxes & interest: $54MFY2025 Operating expenses: $527MFY2025 Cost of revenue: $612M$1.36BFY2025FY2026 Net income: $97MFY2026 Taxes & interest: $59MFY2026 Operating expenses: $631MFY2026 Cost of revenue: $546M$1.33BFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-07-28
  • 2026-07-28DirectorAward2,538—
  • 2026-07-28DirectorAward2,538—
  • 2026-07-28DirectorAward2,538—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Haemonetics Corporation do?

Haemonetics is a global medical technology company that develops equipment and software for collecting and processing blood plasma and blood components.

When did HAE last file with the SEC?

Haemonetics Corporation's most recent SEC filing on record is a DEF 14A filed 2026-06-09. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 02:39 UTC. This page is also available as JSON at /api/data?ticker=HAE and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for HAE and 5,000+ tickers.

Create a free account — keep HAE
For your agent
GET /api/data?ticker=HAE

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt